Literature DB >> 18519667

Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer.

Dmitri V Rozanov1, Alexei Y Savinov, Roy Williams, Kang Liu, Vladislav S Golubkov, Stan Krajewski, Alex Y Strongin.   

Abstract

Invasion-promoting MT1-MMP is directly linked to tumorigenesis and metastasis. Our studies led us to identify those genes, the expression of which is universally linked to MT1-MMP in multiple tumor types. Genome-wide expression profiling of MT1-MMP-overexpressing versus MT1-MMP-silenced cancer cells and a further data mining analysis of the preexisting expression database of 190 human tumors of 14 cancer types led us to identify 11 genes, the expression of which correlated firmly and universally with that of MT1-MMP (P < 0.00001). These genes included regulators of energy metabolism (NNT), trafficking and membrane fusion (SLCO2A1 and ANXA7), signaling and transcription (NR3C1, JAG1, PI3K delta, and CK2 alpha), chromatin rearrangement (SMARCA1), cell division (STK38/NDR1), apoptosis (DAPK1), and mRNA splicing (SNRPB2). Our subsequent extensive analysis of cultured cells, tumor xenografts, and cancer patient biopsies supported our data mining. Our results suggest that transcriptional reprogramming of the specific downstream genes, which themselves are associated with tumorigenesis, represents a distinctive "molecular signature" of the proteolytically active MT1-MMP. We suggest that the transactivation activity of MT1-MMP contributes to the promigratory cell phenotype, which is induced by this tumorigenic proteinase. The activated downstream gene network then begins functioning in unison with MT1-MMP to rework the signaling, transport, cell division, energy metabolism, and other critical cell functions and to commit the cell to migration, invasion, and, consequently, tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519667      PMCID: PMC2659615          DOI: 10.1158/0008-5472.CAN-07-6458

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Nicotinamide nucleotide transhydrogenase: a key role in insulin secretion.

Authors:  Helen Freeman; Kenju Shimomura; Emma Horner; Roger D Cox; Frances M Ashcroft
Journal:  Cell Metab       Date:  2006-01       Impact factor: 27.287

2.  A cancer cell metalloprotease triad regulates the basement membrane transmigration program.

Authors:  Kevin Hotary; Xiao-Yan Li; Edward Allen; Susan L Stevens; Stephen J Weiss
Journal:  Genes Dev       Date:  2006-09-18       Impact factor: 11.361

3.  O-glycosylation regulates autolysis of cellular membrane type-1 matrix metalloproteinase (MT1-MMP).

Authors:  Albert G Remacle; Alexei V Chekanov; Vladislav S Golubkov; Alexei Y Savinov; Dmitri V Rozanov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2006-04-20       Impact factor: 5.157

4.  Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice.

Authors:  Dmitri V Rozanov; Alexei Y Savinov; Vladislav S Golubkov; Stephen Tomlinson; Alex Y Strongin
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 5.  MT1-MMP: a key regulator of cell migration in tissue.

Authors:  Yoshifumi Itoh
Journal:  IUBMB Life       Date:  2006-10       Impact factor: 3.885

6.  Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells.

Authors:  Nagayasu Egawa; Naohiko Koshikawa; Taizo Tomari; Kazuki Nabeshima; Toshiaki Isobe; Motoharu Seiki
Journal:  J Biol Chem       Date:  2006-10-18       Impact factor: 5.157

7.  Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1alpha-independent manner.

Authors:  A Miyoshi; Y Kitajima; T Ide; K Ohtaka; H Nagasawa; Y Uto; H Hori; K Miyazaki
Journal:  Int J Oncol       Date:  2006-12       Impact factor: 5.650

8.  Membrane type-1 matrix metalloproteinase (MT1-MMP) exhibits an important intracellular cleavage function and causes chromosome instability.

Authors:  Vladislav S Golubkov; Sarah Boyd; Alexei Y Savinov; Alexei V Chekanov; Andrei L Osterman; Albert Remacle; Dmitri V Rozanov; Stephen J Doxsey; Alex Y Strongin
Journal:  J Biol Chem       Date:  2005-05-04       Impact factor: 5.157

9.  Membrane type-1 matrix metalloproteinase confers aneuploidy and tumorigenicity on mammary epithelial cells.

Authors:  Vladislav S Golubkov; Alexey V Chekanov; Alexey Y Savinov; Dmitri V Rozanov; Natalya V Golubkova; Alex Y Strongin
Journal:  Cancer Res       Date:  2006-11-01       Impact factor: 12.701

10.  Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration.

Authors:  Takahisa Takino; Yumi Watanabe; Miyuki Matsui; Hisashi Miyamori; Tomoya Kudo; Motoharu Seiki; Hiroshi Sato
Journal:  Exp Cell Res       Date:  2006-02-13       Impact factor: 3.905

View more
  32 in total

1.  Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer.

Authors:  Diaa Al-Raawi; Helal Abu-El-Zahab; Mohamed El-Shinawi; Mona Mostafa Mohamed
Journal:  Int J Clin Exp Med       Date:  2011-10-11

2.  Potential relation of aberrant proteolysis of human protein tyrosine kinase 7 (PTK7) chuzhoi by membrane type 1 matrix metalloproteinase (MT1-MMP) to congenital defects.

Authors:  Vladislav S Golubkov; Alexander E Aleshin; Alex Y Strongin
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

3.  MT1-MMP regulates the PI3Kδ·Mi-2/NuRD-dependent control of macrophage immune function.

Authors:  Ryoko Shimizu-Hirota; Wanfen Xiong; B Timothy Baxter; Steven L Kunkel; Ivan Maillard; Xiao-Wei Chen; Farideh Sabeh; Rui Liu; Xiao-Yan Li; Stephen J Weiss
Journal:  Genes Dev       Date:  2012-02-15       Impact factor: 11.361

4.  Gene expression signatures of angiocidin and darapladib treatment connect to therapy options in cervical cancer.

Authors:  Martin Koch; Michael Wiese
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-09       Impact factor: 4.553

Review 5.  Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.

Authors:  Odile Filhol; Sofia Giacosa; Yann Wallez; Claude Cochet
Journal:  Cell Mol Life Sci       Date:  2015-05-20       Impact factor: 9.261

6.  Biochemical evidence of the interactions of membrane type-1 matrix metalloproteinase (MT1-MMP) with adenine nucleotide translocator (ANT): potential implications linking proteolysis with energy metabolism in cancer cells.

Authors:  Ilian A Radichev; Albert G Remacle; Nor Eddine Sounni; Sergey A Shiryaev; Dmitri V Rozanov; Wenhong Zhu; Natalya V Golubkova; Tatiana I Postnova; Vladislav S Golubkov; Alex Y Strongin
Journal:  Biochem J       Date:  2009-04-28       Impact factor: 3.857

7.  Insights into ectodomain shedding and processing of protein-tyrosine pseudokinase 7 (PTK7).

Authors:  Vladislav S Golubkov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

8.  New Strategies for the Next Generation of Matrix-Metalloproteinase Inhibitors: Selectively Targeting Membrane-Anchored MMPs with Therapeutic Antibodies.

Authors:  Laetitia Devy; Daniel T Dransfield
Journal:  Biochem Res Int       Date:  2010-10-28

9.  In vivo and in vitro effect of hepatocarcinoma lymph node metastasis by upregulation of Annexin A7 and relevant mechanisms.

Authors:  Xian-Yan Wang; Feng Gao; Yu-Rong Sun; Lu-Lu Bai; Mohammed Mohammed Ibrahim; Bo Wang; Jian-Wu Tang
Journal:  Tumour Biol       Date:  2015-08-11

Review 10.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.